Latest Breaking News On - Richarda markus - Page 1 : comparemela.com

Dantari s Novel High-Capacity Drug Conjugate DAN-222 Shows Promising Antitumor Activity in Patients with Metastatic HER2-Negative Breast Cancer

Dantari s Novel High-Capacity Drug Conjugate DAN-222 Shows Promising Antitumor Activity in Patients with Metastatic HER2-Negative Breast Cancer
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesSara hurvitzSaraa hurvitzRichard markusRicharda markusPrnewswire dantari incFred hutchinson cancer centerUniversity of washington department medicineHenryb gonzalez convention centerClinical research divisionDantari incDivision of hematologySan antonio breast cancer symposiumAntonio breast cancer symposiumWashington department

Dantari Gets $47M For Tumor Medicine Effort

Dantari Gets $47M For Tumor Medicine Effort
socaltech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from socaltech.com Daily Mail and Mail on Sunday newspapers.

Al iskandariyahRicharda markusSean harperFor tumor medicine effortOaks based dantariWestlake village biopartnersCorner venturesAlexandria venture investments

Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors

/PRNewswire/ Dantari, Inc. ("Dantari"), a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers.

San antonioUnited statesAl iskandariyahWestlake villageLos angelesRicharda markusTim hagertyBiopartners westlakeSaraa hurvitzMark davisSean harperPascal touchonPrnewswire dantari incJonsson comprehensive cancer center clinical research unitBreast cancer clinical trials programCalifornia institute of technology caltech

Dantari Raises $47M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Al iskandariyahRicharda markusSean harperThousand oaksWestlake village biopartnersCorner venturesAlexandria venture investmentsTargeted high capacity drug conjugate